Evolution of nanomedicine is the re-design of synthetic and biological carriers to implement
novel theranostic platforms. In recent years, bacteriophage research favors this process …

Cancer immunotherapy aimed at boosting cancer-specific immunoresponses to eradicate
tumor cells has evolved as a new treatment modality. Nanoparticles incorporating antigens …

Bacteriophages have emerged as versatile tools in the field of bioengineering, with
enormous potential in tissue engineering, vaccine development, and immunotherapy. The …

Background DNA vaccines have emerged as an attractive approach for the generation of
cytotoxic T lymphocytes (CTL). In our previous study, we found That Toll like receptor (TLR) …

Background Cervical cancer is the second-most-common cause of malignancies in women
worldwide, and the oncogenic activity of the human papilloma virus types (HPV) E7 protein …

We have investigated whether poly (I: C) Toll-like receptor 3 (TLR3) and resiquimod Toll-like
receptor 7 (TLR7) agonists can serve as vaccine adjuvants and promote the efficiency of …

Background: Genistein (GEN), a naturally occurring flavonoid present in soy bean, has
attracted scientific interest for its possible benefits in cancer. Objective: The potential …

The effective delivery of therapeutic agents is as important as the active therapeutic agent
because it may make or mar the outcome. Traditional/conventional drug delivery systems …

Hepatitis C virus (HCV) chronic infection is a worldwide health problem, and numerous
efforts have been invested to develop novel vaccines. An efficient vaccine requires broad …

The increasing interest in bacteriophage technology has prompted its novel applications to
treat different medical conditions, most interestingly cancer. Due to their high specificity …